Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2124 | 4628 | 25.2 | 46% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
6530 | 1405 | TORASEMIDE//TORSEMIDE//FUROSEMIDE |
10333 | 1006 | HYPERKALEMIA//KAYEXALATE//HYPERKALAEMIA |
14685 | 687 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
16591 | 580 | AMILORIDE DETERMINATION//FUROSEMIDE DETERMINATION//CHERRY SYRUP |
22343 | 328 | INDAPAMIDE//CLIN NUTR METAB DIS//PHARMACOL PHYSIOPATHOL CARDIOVASC |
24346 | 263 | M17055//1 2 BENZISOXAZOLE//URICOSURIC ACTIVITY |
26884 | 200 | CAS 396 01 0//CRYSTALLURIA//CALCULI ANALYSIS |
32989 | 99 | TRICEPS SKINFOLD//OESTROPROGESTATIVE// |
34837 | 60 | UNITE PHARMACOEPIDEMIOL EA 3696//BLOOD POTASSIUM//HYPERGLUCAGONAEMIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TORASEMIDE | Author keyword | 70 | 63% | 2% | 70 |
2 | HYPERKALEMIA | Author keyword | 61 | 28% | 4% | 188 |
3 | FUROSEMIDE | Author keyword | 27 | 15% | 4% | 171 |
4 | TORSEMIDE | Author keyword | 27 | 71% | 0% | 22 |
5 | INDAPAMIDE | Author keyword | 24 | 31% | 1% | 66 |
6 | DIURETICS | Author keyword | 19 | 11% | 3% | 157 |
7 | KAYEXALATE | Author keyword | 19 | 74% | 0% | 14 |
8 | HYPERKALAEMIA | Author keyword | 15 | 28% | 1% | 44 |
9 | LOOP DIURETICS | Author keyword | 13 | 25% | 1% | 46 |
10 | TRIAMTERENE | Author keyword | 12 | 38% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TORASEMIDE | 70 | 63% | 2% | 70 | Search TORASEMIDE | Search TORASEMIDE |
2 | HYPERKALEMIA | 61 | 28% | 4% | 188 | Search HYPERKALEMIA | Search HYPERKALEMIA |
3 | FUROSEMIDE | 27 | 15% | 4% | 171 | Search FUROSEMIDE | Search FUROSEMIDE |
4 | TORSEMIDE | 27 | 71% | 0% | 22 | Search TORSEMIDE | Search TORSEMIDE |
5 | INDAPAMIDE | 24 | 31% | 1% | 66 | Search INDAPAMIDE | Search INDAPAMIDE |
6 | DIURETICS | 19 | 11% | 3% | 157 | Search DIURETICS | Search DIURETICS |
7 | KAYEXALATE | 19 | 74% | 0% | 14 | Search KAYEXALATE | Search KAYEXALATE |
8 | HYPERKALAEMIA | 15 | 28% | 1% | 44 | Search HYPERKALAEMIA | Search HYPERKALAEMIA |
9 | LOOP DIURETICS | 13 | 25% | 1% | 46 | Search LOOP+DIURETICS | Search LOOP+DIURETICS |
10 | TRIAMTERENE | 12 | 38% | 1% | 25 | Search TRIAMTERENE | Search TRIAMTERENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TORASEMIDE | 60 | 64% | 1% | 58 |
2 | TORSEMIDE | 52 | 82% | 1% | 31 |
3 | PIRETANIDE | 38 | 86% | 0% | 19 |
4 | FUROSEMIDE | 37 | 16% | 5% | 219 |
5 | LOOP DIURETICS | 34 | 33% | 2% | 86 |
6 | SERUM POTASSIUM | 31 | 38% | 1% | 65 |
7 | INTESTINAL NECROSIS | 26 | 68% | 0% | 23 |
8 | PLASMA POTASSIUM | 25 | 38% | 1% | 53 |
9 | DIURETICS | 25 | 17% | 3% | 135 |
10 | FRUSEMIDE | 23 | 28% | 2% | 70 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Diuretic therapy | 1998 | 230 | 62 | 81% |
Potassium disorders - clinical spectrum and emergency management | 2006 | 46 | 47 | 79% |
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system | 2004 | 195 | 44 | 39% |
Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure | 2010 | 56 | 40 | 48% |
Hyperkalemia revisited | 2006 | 51 | 30 | 63% |
HEPARIN-INDUCED ALDOSTERONE SUPPRESSION AND HYPERKALEMIA | 1995 | 82 | 27 | 78% |
Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management | 2014 | 6 | 37 | 46% |
Loop diuretics: from the Na-K-2Cl transporter to clinical use | 2003 | 46 | 84 | 67% |
TORASEMIDE - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY | 1995 | 59 | 53 | 83% |
Management of hyperkalemia in dialysis patients | 2007 | 24 | 53 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN NUTR METAB DIS | 4 | 75% | 0.1% | 3 |
2 | PHARMACOL PHYSIOPATHOL CARDIOVASC | 4 | 75% | 0.1% | 3 |
3 | DRUG CIM | 1 | 38% | 0.1% | 3 |
4 | AUSTRALIA CLIN EXCELLENCE THER EUT | 1 | 50% | 0.0% | 1 |
5 | BIOMOL ORGAN SYNTH | 1 | 50% | 0.0% | 1 |
6 | CHU HEDI CHAKER SFAX | 1 | 50% | 0.0% | 1 |
7 | CLEVELAND CLIN LERNER MED CWRU | 1 | 50% | 0.0% | 1 |
8 | CLIN FUNCT DIAGNOST | 1 | 50% | 0.0% | 1 |
9 | DEV PHARMACOL PERINATAL UNIT | 1 | 50% | 0.0% | 1 |
10 | DIPARTIMENTO CARDIOTHORAC | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017215 | GITELMANS SYNDROME//GITELMAN SYNDROME//BARTTER SYNDROME |
2 | 0.0000016150 | CARVEDILOL//NEBIVOLOL//BETA BLOCKERS |
3 | 0.0000015986 | RENAL VEIN THROMBOSIS//NEPHROL UROL TRANSPLANT IMMUNOL DERMATOL A//NEPHROTIC EDEMA |
4 | 0.0000014066 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM |
5 | 0.0000013110 | 11 BETA HYDROXYSTEROID DEHYDROGENASE//ALDOSTERONE//EPLERENONE |
6 | 0.0000011846 | HYPONATRAEMIA//CENTRAL PONTINE MYELINOLYSIS//SIADH |
7 | 0.0000011620 | CICLETANINE//TIROPRAMIDE//MUSANGA CECROPIOIDES |
8 | 0.0000011044 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
9 | 0.0000010306 | KCC2//ENAC//EPITHELIAL SODIUM CHANNEL |
10 | 0.0000009055 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |